NCAM1 and myelodysplastic syndrome: The frequency and absolute number of peripheral CD56+CD16+ NK cells were also markedly decreased in myelodysplastic syndromes (MDS) and AML secondary to MDS patients (n = 130) compared to normal subjects (n = 40).